Literature DB >> 27061234

Folate deficiency and over-supplementation causes impaired folate metabolism: Regulation and adaptation mechanisms in Caenorhabditis elegans.

Martina Ortbauer1, Doris Ripper1, Thomas Fuhrmann1,2, Maximilian Lassi1, Sandra Auernigg-Haselmaier1, Christina Stiegler1, Jürgen König1.   

Abstract

SCOPE: Impaired folate metabolism increases the risk of birth defects, neurodegenerative and cardiovascular disease, osteoporosis and cancer. We used Caenorhabditis elegans to investigate impaired folate metabolism by RNA interference of key enzymes in the methionine synthase (MS) and thymidylate synthase (TS) cycle and by folate deficiency and over-supplementation feeding studies. METHODS AND
RESULTS: Folate status is influenced by genetic variations (polymorphisms), folate deficiency and supplementation. Single RNAi of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) and MS revealed that gene regulation is largely affected in both folate cycles. Adaptation requires a close transcriptional connection between TS and MS cycle. Coupled DHFR and MS expression is required to balance both cycles, but seems to reduce the overall rate of folate conversion. Feeding studies showed that folate over-supplementation to functioning metabolism inactivates MS and MTHFR expression and enhances TS activity, which favors DNA synthesis over methylation reactions. Folate deficiency disrupted homeostasis by favoring TS cycle and led to malformation in C. elegans offspring. Embryos show aneuploidy and are nonviable lacking DNA repair during meiotic stage of diakinesis.
CONCLUSION: Single gene silencing alters gene expression in both cycles and disrupts folate homeostasis. Folate over-supplementation and deficiency favors TS over MS cycle and causes prophase DNA damage.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Folate deficiency; Folic acid over-supplementation; Impaired folate metabolism; Polymorphisms; RNAi

Mesh:

Substances:

Year:  2016        PMID: 27061234     DOI: 10.1002/mnfr.201500819

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  8 in total

Review 1.  Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps.

Authors:  Michael Fenech
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

2.  Excessive Folic Acid Mimics Folate Deficiency in Human Lymphocytes.

Authors:  Khadijah I Alnabbat; Ali M Fardous; Diane C Cabelof; Ahmad R Heydari
Journal:  Curr Issues Mol Biol       Date:  2022-03-23       Impact factor: 2.976

Review 3.  Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease.

Authors:  Barbara Troesch; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-12-10       Impact factor: 5.717

Review 4.  Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature.

Authors:  Catia Daniela Cantarella; Denise Ragusa; Marco Giammanco; Sabrina Tosi
Journal:  Genes Nutr       Date:  2017-06-02       Impact factor: 5.523

Review 5.  High Folate, Perturbed One-Carbon Metabolism and Gestational Diabetes Mellitus.

Authors:  Jessica M Williamson; Anya L Arthurs; Melanie D Smith; Claire T Roberts; Tanja Jankovic-Karasoulos
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

6.  High Dietary Folic Acid Intake Is Associated with Genomic Instability in Peripheral Lymphocytes of Healthy Adults.

Authors:  Khadijah I Alnabbat; Ali M Fardous; Aiman Shahab; Andrew A James; Manhel R Bahry; Ahmad R Heydari
Journal:  Nutrients       Date:  2022-09-23       Impact factor: 6.706

7.  A bacterial route for folic acid supplementation.

Authors:  Claire Maynard; Ian Cummins; Jacalyn Green; David Weinkove
Journal:  BMC Biol       Date:  2018-06-15       Impact factor: 7.431

Review 8.  Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer.

Authors:  Yu Takeda; Ryota Chijimatsu; Andrea Vecchione; Takahiro Arai; Toru Kitagawa; Ken Ofusa; Masami Yabumoto; Takaaki Hirotsu; Hidetoshi Eguchi; Yuichiro Doki; Hideshi Ishii
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.